Interdisciplinary Comprehensive Arm Rehab Evaluation (I-CARE) Stroke
跨学科综合手臂康复评估 (I-CARE) 中风
基本信息
- 批准号:8115809
- 负责人:
- 金额:$ 292.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdultAftercareBilateralCaringChronic PhaseClinicalClinical TrialsCommunity TrialComplexDevelopmentDoseEffectivenessElementsEnvironmentEvaluationEvidence based treatmentExerciseFamilyFutureGaitGoalsHandHand functionsHome environmentHourHouseholdHybridsImpairmentInpatientsInterventionKinesiologyLaboratoriesLearningLegLeisure ActivitiesLevel of EvidenceLimb structureLower ExtremityMasksMeasuresMedicareModalityMonitorMotorMovementOccupational TherapyOutcome MeasureOutpatientsParesisParticipantPatient Self-ReportPatientsPerformancePhaseProtocols documentationQuality of lifeRandomizedRandomized Controlled TrialsRecommendationRecoveryRecovery of FunctionRehabilitation therapyResidual stateResolutionReversal LearningSecondary toSelf CareSelf PerceptionServicesSiteSolutionsStrokeSubgroupTestingTimeTrainingTranslationsTravelUpper ExtremityWalkingWolvesabstractingacute strokearmbasecomparative efficacyconstraint induced therapycostdesigndisabilityeffective interventionevidence baseexperiencefunctional outcomesimprovedinstrumentmotor controlmotor impairmentmotor learningmuscle strengthpost interventionpost strokeprimary outcomeprogramsremediationsecondary outcomeskill acquisitionskillsstroke recoverystroke rehabilitationsystematic reviewtooltreatment as usualtrend
项目摘要
Project Summary/Abstract
Residual disability after stroke is substantial, with about 65% of patients at 6 months unable to incorporate the
paretic hand effectively into daily activities. In turn, this degree of functional deficit contributes to a reduced
quality of life after stroke. The primary objective of I-CARE (Interdisciplinary Comprehensive Arm Rehabilitation
Evaluation) is to improve outpatient therapy for arm paresis after stroke. We will conduct a Phase III, singleblind,
multi-center, randomized control trial to investigate the effectiveness of ASAP (Accelerated Skill
Acquisition Program), a focused, intense, evidence-based, upper extremity rehabilitation program. ASAP
combines aspects of constraint-induced therapy, skill-based/impairment-mitigating task-specific training with
embedded motivational enhancements and includes 30 hours of one-on-one therapy initiated during the early
post-acute outpatient interval (1-3 months) after stroke.
This RCT has one primary aim: Compare ASAP to a dose equivalent usual and customary occupational
therapy (high dose) group. There are two secondary aims: a) Compare ASAP to a true (monitoring only) usual
and customary therapy group (low dose) and b) Compare the high dose usual and customary occupational
therapy group to the low dose usual and customary occupational therapy group.
We will randomize 360 adults, within one to three months of stroke onset, with mild to moderate upper
extremity impairment. Our primary outcome is a performance-based arm function test, Wolf Motor Function
Test (WMFT) at one year after participation. Secondary outcomes include patients¿ self-perception of paretic
hand function, a domain of the Stroke Impact Scale (SIS) and the full SIS. Specific subgroup analyses will
explore important moderating factors including duration from onset, stroke type, and motor impairment.
Given the trend toward diminished total reimbursable time for stroke rehabilitation, our ultimate goal is to
provide evidence toward an optimal allocation of therapy services within the approved number of treatment
sessions that will reduce disability, lessen the societal burden, and provide a standardized evidence-based
treatment useful for the rehabilitation clinician and future clinical trialist.
项目总结/摘要
中风后的残余残疾是相当大的,约65%的患者在6个月时不能将
有效地将麻痹的手纳入日常活动中。反过来,这种程度的功能缺陷有助于减少
中风后的生活质量I-CARE的主要目标(跨学科综合手臂康复)
评估)是为了改善中风后手臂麻痹的门诊治疗。我们将进行第三阶段,单盲,
多中心、随机对照试验,研究ASAP(加速技能)的有效性
收购计划),一个集中的,密集的,循证的,上肢康复计划。ASAP
结合了约束诱导疗法、基于技能/减轻损伤的特定任务训练,
嵌入式激励增强,包括30小时的一对一治疗,在早期
卒中后急性期后门诊间隔(1-3个月)。
这项随机对照试验有一个主要目的:将ASAP与剂量等效的常规和习惯职业
治疗组(高剂量组)。有两个次要目标:a)将ASAP与真实(仅监测)常规进行比较
B)常规治疗组(低剂量组)与常规治疗组(高剂量组)比较
治疗组改为小剂量常规作业治疗组。
我们将随机抽取360名中风发作后1 - 3个月内的成年人,
肢体损伤我们的主要结果是基于表现的手臂功能测试,Wolf运动功能
参加后一年进行测试(WMFT)。次要结局包括患者对麻痹的自我感觉
手功能,中风影响量表(SIS)的一个领域和完整的SIS。特定亚组分析将
探索重要的调节因素,包括发病时间、卒中类型和运动障碍。
考虑到中风康复的总可报销时间减少的趋势,我们的最终目标是
提供在批准的治疗次数内最佳分配治疗服务的证据
会议将减少残疾,减轻社会负担,并提供一个标准化的循证医学。
治疗有用的康复临床医生和未来的临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolee J Winstein其他文献
Carolee J Winstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carolee J Winstein', 18)}}的其他基金
American Society of Neurorehabilitation (ASNR): 2016 Annual Scientific Meeting
美国神经康复学会 (ASNR):2016 年度科学会议
- 批准号:
9193917 - 财政年份:2016
- 资助金额:
$ 292.13万 - 项目类别:
Interdisciplinary Comprehensive Arm Rehab Evaluation (I-CARE) Stroke
跨学科综合手臂康复评估 (I-CARE) 中风
- 批准号:
7696279 - 财政年份:2008
- 资助金额:
$ 292.13万 - 项目类别:
NEUROREHABILITATION THERAPEUTICS IN STROKE PATIENTS
中风患者的神经康复治疗
- 批准号:
7382211 - 财政年份:2006
- 资助金额:
$ 292.13万 - 项目类别:
NEUROREHABILITATION THERAPEUTICS IN STROKE PATIENTS
中风患者的神经康复治疗
- 批准号:
7171431 - 财政年份:2005
- 资助金额:
$ 292.13万 - 项目类别:
III STEP: Linking Movement Science and Intervention
第三步:将运动科学与干预联系起来
- 批准号:
6838336 - 财政年份:2004
- 资助金额:
$ 292.13万 - 项目类别:
NEUROREHABILITATION THERAPEUTICS IN STROKE PATIENTS
中风患者的神经康复治疗
- 批准号:
6983034 - 财政年份:2004
- 资助金额:
$ 292.13万 - 项目类别:
Brain and Behavior Correlates of Arm Rehabilitation
手臂康复的大脑和行为相关性
- 批准号:
6798626 - 财政年份:2002
- 资助金额:
$ 292.13万 - 项目类别:
Brain and Behavior Correlates of Arm Rehabilitation
手臂康复的大脑和行为相关性
- 批准号:
6653055 - 财政年份:2002
- 资助金额:
$ 292.13万 - 项目类别:
Brain and Behavior Correlates of Arm Rehabilitation
手臂康复的大脑和行为相关性
- 批准号:
6542031 - 财政年份:2002
- 资助金额:
$ 292.13万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 292.13万 - 项目类别:
Research Grant














{{item.name}}会员




